Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction

Libby P Molecular bases of the acute coronary syndromes Circulation 1995 91 2844–2850

Ross R Atherosclerosis: an inflammatory disease N Engl J Med 1999 340 115–126

Baggiolini M, Dewald B, Moser B Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines Adv Immunol 1994 55 97–179

Luster AD Chemokines: chemotactic cytokines that mediate inflammation N Engl J Med 1998 338 436–445

Nelken NA, Coughlin SR, Gordon D, Wilcox JN Monocyte chemoattractant protein-1 in human atheromatous plaques J Clin Invest 1991 88 1121–1127

Ylä-Herttuala S, Lipton BA, Sarkioja ME et al Expression of monocyte chemotactic protein-1 in macrophage rich areas of human and rabbit atherosclerotic lesions Proc Natl Acad Sci USA 1991 88 5252–5256

Damas JK, Gullestad L, Ueland T et al CXC-chemokines, a new group of cytokines in congestive heart failure – possible role of platelets and monocytes Cardiovasc Res 2000 45 428–436

Reape TJ, Groot PH Chemokines and atherosclerosis Atherosclerosis 1999 147 213–225

Weber KS, Nelson PJ, Grone HJ, Weber C Expression of CCR2 by endothelial cells: implications for MCP-1 mediated wound injury repair and in vivo inflammatory activation of endothelium Arterioscl Thromb Vasc Biol 1999 19 2085–2093

Rollins BJ, Yoshimura T, Leonard EJ, Pober JS Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE Am J Pathol 1990 136 1229–1233

Yu X, Dluz S, Graves DT et al Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolaemic primates Proc Natl Acad Sci USA 1992 89 6953–6957

Nelken NA, Coughlin SR, Gordon D, Wicox JN Monocyte chemoattractant protein 1 in human atheromatous plaques J Clin Invest 1991 88 1121–1127

Mantovani A The chemokine system: redundancy for robust outputs Immunol Today 1999 20 254–257

Hayes IM, Jorda NJ, Towers S et al Human vascular smooth cells express receptors for CC chemokines Arterioscler Thromb Vasc Biol 1998 18 397–403

Schecter AD, Calderon TM, Berman AB et al Human vascular smooth muscle cells possess functional CCR5 J Biol Chem 2000 275 5466–5471

Boring L, Gosling J, Cleary M, Charo IF Decreased lesion formation in CCR−/− mice reveals a role for chemokines in the initiation of atherosclerosis Nature 1998 394 894–897

Berger EA HIV entry and tropism: the chemokine receptor connection Aids 1997 11 (Suppl A) S3–S16

Dean M, Carrington M, Winckler C et al Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene Science 1996 273 1856–1862

Lui R, Paxton WA, Choe S et al Homozygous defect in HIV-1 infection Cell 1996 86 367–377

Samson M, Libert F, Doranz BJ et al Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene Nature 1996 382 722–725

Huang Y, Paxton WA, Wolinsky SM et al The role of a mutant CCR5 allele in HIV-1 transmission and disease progression Nat Med 1996 2 1240–1243

Kostrikis LG, Huang Y, Moore JP et al A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation Nat Med 1998 4 350–354

Mummidi S, Ahuja SA, González E et al Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression Nat Med 1998 4 786–793

Benkirane M, Jin DY, Chun RF, Koup RA, Jeang KT Mechanism of transdominant inhibition of CCR5 mediated HIV-infection by ccr5Δ32 J Biol Chem 1997 272 30603–30606

Matsumori A, Furukawa Y, Hashimoto T et al Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction J Mol Cell Cardiol 1997 29 419–423

Kuziel WA, Morgan SJ, Dawson TC et al Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in the CC chemokine receptor 2 Proc Natl Acad Sci USA 1997 94 12053–12058

Kurihara T, Warr G, Loy J, Bravo R Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor J Exp Med 1997 186 1757–1762

Alvarez V, López-Larrea C, Coto E Mutational analysis of the CCR5 and CXCR4 genes (HIV-1 co-receptors) in resistance to HIV-1 infection and AIDS development among intravenous drug users Hum Genet 1998 192 483–486

Hall IP, Wheatley A, Christie G et al Association of CCR5 Δ32 with reduced risk of asthma Lancet 1999 354 1264–1265

Garred P, Madsen HO, Petersen J et al CC chemokine receptor 5 polymorphism in rheumatoid arthritis J Rheumatol 1998 25 1462–1465

Cooke SP, Forrest G, Venables PJ et al The delta32 deletion of CCR5 receptor in rheumatoid arthritis Arthritis Rheum 1998 41 1135

Zapico I, Coto E, Rodríguez A et al CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis Genes Immun 2000 1 288–289

Francis SE, Camp NJ, Dewberry RM et al Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease Circulation 1999 99 861–866